Old Web
English
Sign In
Acemap
>
authorDetail
>
Kirsten Renke
Kirsten Renke
Medicine
Internal medicine
Digoxin
Flecainide
Amiodarone
5
Papers
256
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125 Immunological Response and Survival (Phase Ib/II)
2004
Clinical Cancer Research
Silke Reinartz
S. Köhler
H. Schlebusch
Karl Krista
P. Giffels
Kirsten Renke
Jens Huober
V. Möbus
Rolf Kreienberg
Andreas duBois
Paul Sabbatini
U. Wagner
Show All
Source
Cite
Save
Citations (129)
Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001.
2001
Clinical Cancer Research
U. Wagner
S. Köhler
Silke Reinartz
P. Giffels
Jens Huober
Kirsten Renke
H. Schlebusch
Hans-Jürgen Biersack
V. Möbus
Rolf Kreienberg
T. Bauknecht
D. Krebs
Diethelm Wallwiener
Show All
Source
Cite
Save
Citations (108)
Digoxin, flecainide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate.
2000
Therapeutic Drug Monitoring
J. Schmolling
Kirsten Renke
O. Richter
K. Pfeiffer
H. Schlebusch
Tobias Höller
Show All
Source
Cite
Save
Citations (19)
Transplacental transfer of digoxin, flecainide and amiodarone and the effect of an elevated umbilical venous pressure on the transfer rate
1998
Journal of The Society for Gynecologic Investigation
J. Schmolling
Kirsten Renke
O. Richter
K. Pfeiffer
T. Höller
Show All
Source
Cite
Save
Citations (0)
1